AI CAPITAL INTELLIGENCE
利德健康 · Pre-A++ · CNY 20,000,000–90,000,000 (reported range) · 2026-09-28
Financing facts, at a glance
利德健康: financing disclosed on 2026-09-28, Pre-A++, CNY 20,000,000–90,000,000 (reported range). Named investors: 上海国际集团投资有限公司. This is the amount disclosed for the financing, not a company valuation or an individual investor commitment.
Original source 1 · Original source 2 · Original source 3 · Original source 4
利德健康 is recorded in the Industry AI / Drug discovery & life sciences segment. The disclosed financing is Pre-A++, with an amount of CNY 20,000,000–90,000,000 (reported range). Named investors include 上海国际集团投资有限公司.
- Disclosed company name
- 利德健康科技（广州）有限公司
- Disclosure date
- 2026-09-28
- Round
- Pre-A++
- Financing amount
- CNY 20,000,000–90,000,000 (reported range)
- Market coverage
- China
- Sector
- Industry AI / Drug discovery & life sciences
- Product form
Disclosed investors
上海国际集团投资有限公司
Original sources
- Source 1 · www.sohu.com
- Source 2 · www.vbdata.cn
- Source 3 · www.leadhealthcare.ai
- Source 4 · media.qimingpian.cn
Record reviewed as of . Reported ranges and lower bounds are retained. Financing proceeds are not company valuation.